News
At-Home Protocol Uses OTC Nerve Activation Tool to Reinforce Stability, Restore Confidence, and Help Reduce Fall Risk in ...
These are the best electric toothbrushes you can buy in every category, from Oral-B Genius X and Bitvae R2 to Waterpik ...
A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...
Spinal Muscular Atrophy treatment is evolving fast, with gene therapy, oral drugs, and next-gen muscle enhancers offering new hope and long-term outcomes. With each breakthrough in SMA treatment, we ...
Ventyx Biosciences has reported encouraging top-line outcomes from its single-centre Phase IIa trial of the central nervous system (CNS)-penetrant NLRP3 inhibitor, VTX3232, in individuals with ...
In patients with Parkinson disease (PD) and comorbid mood dysfunction, psilocybin-assisted therapy is well-tolerated and associated with sustained improvements in depression, anxiety, motor ...
A pediatric occupational therapist brings her love for the outdoors and nature to a camp she started in Harlem for children with special needs.
Results from the Phase 1 trial were shared by Athira at the recent ALS Drug Development Summit in Boston, in an oral presentation titled “ Advancing ATH-1105 for ALS Through Early Clinical and PK Data ...
Genethon unveiled the 2-year follow-up data from its GNT0004 gene therapy clinical trial for Duchenne Muscular Dystrophy (GNT-016-MDYF) at the annual meeting of the American Society of Gene & Cell ...
GNT0004 product confirms its clinical efficacy with stabilization of motor functions in patients treated at the effective dose for up to 2 years. Sustained significant reduction in levels of creatine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results